PRICE T ROWE ASSOCIATES INC /MD/
Position in RLAY — Relay Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$144,226,165
+$125,073,033 QoQ
Shares Held
7,708,507
+300.5% QoQ
Ownership
3.52%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. RLAY ranks #37 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,226,165 | 7,708,507 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,153,132 | 1,924,938 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,920,109 | 1,645,403 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,938,694 | 1,137,681 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,950,737 | 2,875,936 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,111,812 | 3,477,791 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,685,572 | 3,321,741 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,384,459 | 5,280,291 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,854,377 | 5,039,015 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $57,100,654 | 6,879,597 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $94,478,648 | 8,581,167 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $72,401,235 | 8,608,946 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $104,819,692 | 8,345,517 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $113,032,950 | 6,862,960 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $67,125,478 | 4,493,004 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $102,037,690 | 4,561,363 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $88,780,142 | 5,300,307 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $149,641,559 | 4,999,718 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $127,610,522 | 4,155,341 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $51,014,058 | 1,617,953 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $42,937,706 | 1,173,482 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $52,031,030 | 1,505,092 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $32,149,777 | 773,575 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $33,539,710 | 787,502 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||